CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands		Total		Ward Village Homeowners Associations	Total Stockholders' Equity	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests	Noncontrolling Interests Ward Village Homeowners Associations
Balance at the beginning of the period (in shares) at Dec. 31, 2020						56,042,814
Balance at the beginning of the period at Dec. 31, 2020		$ 3,715,023			$ 3,714,603	$ 562	$ 3,947,278	$ (72,556)	$ (38,590)	$ (122,091)	$ 420
Balance at the beginning of the period (in shares) at Dec. 31, 2020										(1,070,558)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest		56,355			56,100			56,100			255
Interest rate swaps, net of tax		17,960	[1]		17,960				17,960
Pension adjustment, net of tax		452	[2]		452				452
Share of investee's other comprehensive income, net of tax expense (benefit)		5,721	[3]		5,721				5,721
Issuance of common shares		(5)			(5)		(5)
Repurchase of common shares (in shares)										(1,023,284)
Repurchase of common shares		(96,620)			(96,620)					$ (96,620)
Stock plan activity (in shares)						130,462				(13,773)
Stock plan activity		11,784			11,784	$ 1	13,145			$ (1,362)
Balance at the end of the period (in shares) at Dec. 31, 2021						56,173,276
Balance at the end of the period at Dec. 31, 2021		3,710,670			3,709,995	$ 563	3,960,418	(16,456)	(14,457)	$ (220,073)	675
Balance at the end of the period (in shares) at Dec. 31, 2021										(2,107,615)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest		184,636			184,533			184,533			103
Interest rate swaps, net of tax		31,698	[1]		31,698				31,698
Pension adjustment, net of tax		(183)	[2]		(183)				(183)
Deconsolidation of Ward Village homeowners’ associations				$ (211)								$ (211)
Teravalis noncontrolling interest		65,046									65,046
Reclassification of the Company’s share of previously deferred derivative gains, net of tax expense	[4]	(6,723)			(6,723)				(6,723)
Share of investee's other comprehensive income, net of tax expense (benefit)	[3]	0
Repurchase of common shares (in shares)										(4,283,874)
Repurchase of common shares		(388,372)			(388,372)					$ (388,372)
Stock plan activity (in shares)						52,997				(32,787)
Stock plan activity		$ 9,551			9,551	$ 1	12,143			$ (2,593)
Balance at the end of the period (in shares) at Dec. 31, 2022		49,801,997				56,226,273
Balance at the end of the period at Dec. 31, 2022		$ 3,606,112			3,540,499	$ 564	3,972,561	168,077	10,335	$ (611,038)	65,613
Balance at the end of the period (in shares) at Dec. 31, 2022		(6,424,276)								(6,424,276)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest		$ (550,708)			(550,951)			(550,951)			243
Interest rate swaps, net of tax		(9,322)	[1]		(9,322)				(9,322)
Pension adjustment, net of tax		259	[2]						259
Teravalis noncontrolling interest		219									219
Share of investee's other comprehensive income, net of tax expense (benefit)	[3]	0
Stock plan activity (in shares)						322,506				(21,628)
Stock plan activity		9,418			9,418	$ 2	11,138			$ (1,722)
Stock conversion to HHH (in shares)						(56,548,779)				6,445,904
Stock conversion to HHH		0				$ (566)	(612,194)			$ 612,760
HHC shares issued to HHH (in shares)						10
Capital transactions with HHH		2,641			2,641		2,779	(138)
Other		$ (22)									(22)
Balance at the end of the period (in shares) at Dec. 31, 2023		10				10
Balance at the end of the period at Dec. 31, 2023		$ 3,058,597			$ 2,992,544	$ 0	$ 3,374,284	$ (383,012)	$ 1,272	$ 0	$ 66,053
Balance at the end of the period (in shares) at Dec. 31, 2023		0								0

[1] Amounts are shown net of deferred tax benefit of $2.7 million for the year ended December 31, 2023, deferred tax expense of $9.5 million for the year ended December 31, 2022, and deferred tax expense of $5.1 million for the year ended December 31, 2021.

[2] The deferred tax impact was not meaningful for the years ended December 31, 2023, 2022, and 2021.

[3] Amount is shown net of deferred tax expense of $1.6 million for the year ended December 31, 2021.

[4] In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 - Investments in Unconsolidated Ventures for additional information.